Live
10x Genomics BlogIs Ark Invest’s Steady Buying Reframing the Long-Term Product Expansion Story At 10x Genomics (TXG)? - simplywall.stEndpoints News#AAD26: Biogen declares Phase 2 lupus success for anti-BDCA2 antibodyFierceBiotechTakeda clears path to FDA with phase 3 data on $4B psoriasis betCellAdvancing precision health discovery in a genetically diverse health systemCellWhole-body molecular and cellular mapping of the laboratory mouseEndpoints News#AAD26: Tanabe’s Phase 3 win for drug targeting rare diseases that cause pain upon light exposureThermo FisherGenerate Investment Management Ltd Has $20.66 Million Stake in Thermo Fisher Scientific Inc. $TMO - MarketBeatEndpoints NewsA week of bolt-on deals; Wave crashes on obesity data; Sanofi partners with TCE startup; and moreIlluminaExchange Traded Concepts Trims Illumina Stock Holdings - National Today10x Genomics BlogJPMorgan Chase & Co. Raises Position in 10x Genomics $TXG - MarketBeatThermo FisherThermo Fisher Scientific Shares Sold by DAVENPORT & Co LLC - National TodayIlluminaExchange Traded Concepts LLC Lowers Stock Holdings in Illumina, Inc. $ILMN - MarketBeat
BioWorld Dec 11, 2025

Meta Pharmaceutical and Moyuan Pharmaceuticals divulge new LDHA inhibitors

Meta Pharmaceutical and Moyuan Pharmaceuticals divulge new LDHA inhibitors

Original
Body unavailable. Use the original source.

Directory

59 All